Legal Opinion
Otsuka Pharmaceutical Co. v. Zydus Pharmaceuticals USA
District Court, D. New Jersey
Decided October 13, 2015No. Civil Action Nos. 14-3168 (JBS/KMW), 14-4671 (JBS/KMW), 14-5878 (JBS/KMW), 14-6398 (JBS/KMW), 14-7252 (JBS/KMW)PublishedCited by 5 opinions
1Opinion of the Court
MEMORANDUM OPINION REGARDING MOTIONS TO DISMISS OT-SUKA’S INFRINGEMENT CLAIMS UNDER THE ’350 PATENT
SIMANDLE, Chief Judge:
These related patent infringement actions under the Hatch-Waxman Act, 35 U.S.C. §§ 271, .281,. generally concern Plaintiff Otsuka Pharmaceutical Co, Ltd.’s (hereinafter, “Otsuka”) position that various generic defendants’ abbreviated new drug. applications (hereinafter, “ANDAs”) infringe the various phtents covering Otsu-ka’s brand name aripiprazole product, Ability®.1
Following the' Court’s decision upon Otsuka’s motions for a preliminary in*517junction and to amend, its…
2Cases cited16 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Skinner v. SwitzerSupreme Court of the United States · 2011
- Alan Schmidt v. John SkolasCourt of Appeals for the Third Circuit · 2014
- Umland v. PLANCO Financial Services, Inc.Court of Appeals for the Third Circuit · 2008
11 more not listed; retrieve them via the Exa API.
3Cited by5 opinions
- Otsuka Pharmaceutical Co. v. Torrent Pharmaceuticals Ltd.District Court, D. New Jersey · 2015
- BRISTOL-MYERS SQUIBB COMPANY v. XSPRAY PHARMA ABDistrict Court, D. New Jersey · 2023
- LEXINGTON LUMINANCE LLC v. BULBRITE INDUSTRIES INCDistrict Court, D. New Jersey · 2023
- NOVAPLAST CORPORATION v. INPLANT, LLCDistrict Court, D. New Jersey · 2021
- NOVAPLAST CORPORATION v. INPLANT, LLCDistrict Court, D. New Jersey · 2021